According to Rob Hillman, CEO of ActivX Biosciences, the ability — and technology — to find low-abundance proteins “is an art.”

Enter the artist, David Campbell, in the new position of vice president of chemistry. Campbell, 42, began his career in biotech but until 1999 couldn’t find the link between the new biology and his own specialty, chemistry. Ruedi Aebersold’s paper on ICAT technology changed Campbell’s outlook. “For the first time, I saw a role for chemistry in proteomics,” he recalls.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.